**Nicosia, Cyprus** – In a significant legislative push, the Cyprus Parliament has recently ratified new regulations designed to bolster patient safety in diagnostic imaging and is poised to extend stringent controls over the burgeoning market of nicotine pouches. These dual decisions, emanating from parliamentary sessions and committee deliberations, underscore a commitment to public health and safety, addressing both established medical practices and emerging consumer products.
On Thursday, lawmakers unequivocally passed legislation mandating the physical presence of a qualified radiologist during all imaging examinations conducted at diagnostic radiology centres. This pivotal amendment, jointly tabled by major political parties including DISY, AKEL, ELAM, and DIPA, rectifies a long-standing ambiguity and reinforces the indispensable role of specialist physicians in interpreting complex medical scans. The legislation also explicitly prohibits the co-location of animal diagnostic services within facilities catering to human patients. Henceforth, veterinary imaging will be confined to dedicated specialist establishments, ensuring a clear demarcation between human and animal healthcare provision. A motion to defer this particular aspect was ultimately unsuccessful, signalling a firm parliamentary resolve.
The implications for radiology centres are immediate and substantial. They are now legally bound to ensure that a certified radiologist is on-site and actively overseeing imaging procedures, thereby enhancing the accuracy and reliability of diagnostic outcomes for patients. The segregation of animal imaging services also promises to streamline operations and potentially elevate the standard of care across both sectors.
Concurrently, the parliamentary Health Committee has forged a consensus on a bill poised to bring nicotine pouches under the purview of existing tobacco control legislation. This proposed amendment to the health protection and smoking control law seeks to classify these tobacco-free, orally consumed products as regulated items, akin to traditional tobacco products. The committee’s deliberations have been comprehensive, involving consultations with key stakeholders, including licensed importers and distributors of nicotine pouches, as well as representatives from the retail sector, such as kiosk owners.
The proposed definition of a nicotine pouch outlines it as an industrially produced, non-inhaled product, devoid of tobacco, designed for oral use and containing nicotine, often in combination with other substances, in a solid format. Crucially, this definition excludes medical or pharmaceutical products. Licensed importers and distributors, acknowledging the need for robust oversight, have themselves advocated for stringent regulatory measures. Their proposals encompass mandatory health warnings prominently displayed on packaging, comprehensive product information, and the implementation of child-resistant packaging mechanisms to mitigate accidental ingestion by minors.
While a formal vote on the nicotine pouch regulation is anticipated before the close of March, the Health Committee expresses a high degree of confidence that the bill will be enacted into law within this timeframe. This proactive approach reflects a growing recognition of nicotine pouches as a product requiring careful management, particularly concerning their accessibility and potential public health impact. The impending regulations are expected to align the sale and marketing of nicotine pouches with those of other nicotine-containing products, thereby establishing a more consistent and comprehensive regulatory framework across Cyprus. The final legislative outcome is awaited with keen interest by both industry participants and public health advocates.